BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34610210)

  • 21. Synthesis, biological evaluation, and structure-activity relationships of new tubulin polymerization inhibitors based on 5-amino-1,2,4-triazole scaffold.
    Yang F; Chen L; Lai JM; Jian XE; Lv DX; Yuan LL; Liu YX; Liang FT; Zheng XL; Li XL; Wei LY; You WW; Zhao PL
    Bioorg Med Chem Lett; 2021 Apr; 38():127880. PubMed ID: 33636303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design of molecular hybrids of phthalimide-triazole agents with potent selective MCF-7/HepG2 cytotoxicity: Synthesis, EGFR inhibitory effect, and metabolic stability.
    Ihmaid SK; Alraqa SY; Aouad MR; Aljuhani A; Elbadawy HM; Salama SA; Rezki N; Ahmed HEA
    Bioorg Chem; 2021 Jun; 111():104835. PubMed ID: 33798850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular diversity of trimethoxyphenyl-1,2,3-triazole hybrids as novel colchicine site tubulin polymerization inhibitors.
    Fu DJ; Li P; Wu BW; Cui XX; Zhao CB; Zhang SY
    Eur J Med Chem; 2019 Mar; 165():309-322. PubMed ID: 30690300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis and biological evaluation of homoerythrina alkaloid derivatives bearing a triazole moiety as PARP-1 inhibitors and as potential antitumor drugs.
    Li S; Li XY; Zhang TJ; Kamara MO; Liang JW; Zhu J; Meng FH
    Bioorg Chem; 2020 Jan; 94():103385. PubMed ID: 31669094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design and synthesis of novel quinoline/chalcone/1,2,4-triazole hybrids as potent antiproliferative agent targeting EGFR and BRAF
    Mohassab AM; Hassan HA; Abdelhamid D; Gouda AM; Youssif BGM; Tateishi H; Fujita M; Otsuka M; Abdel-Aziz M
    Bioorg Chem; 2021 Jan; 106():104510. PubMed ID: 33279248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design and synthesis of novel 1,2,3-triazole-dithiocarbamate hybrids as potential anticancer agents.
    Duan YC; Ma YC; Zhang E; Shi XJ; Wang MM; Ye XW; Liu HM
    Eur J Med Chem; 2013 Apr; 62():11-9. PubMed ID: 23353743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis, and biological evaluation of novel alkylsulfanyl-1,2,4-triazoles as cis-restricted combretastatin A-4 analogues.
    Li YH; Zhang B; Yang HK; Li Q; Diao PC; You WW; Zhao PL
    Eur J Med Chem; 2017 Jan; 125():1098-1106. PubMed ID: 27810596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and Biological Evaluation of Novel Triazoles Linked 7-hydroxycoumarin as Potent Cytotoxic Agents.
    Farooq S; Hussain A; Qurishi MA; Hamid A; Koul S
    Anticancer Agents Med Chem; 2018; 18(11):1531-1539. PubMed ID: 29298653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and anti-gastric cancer activity evaluation of novel triazole nucleobase analogues containing steroidal/coumarin/quinoline moieties.
    Zhao JW; Wu ZH; Guo JW; Huang MJ; You YZ; Liu HM; Huang LH
    Eur J Med Chem; 2019 Nov; 181():111520. PubMed ID: 31404863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Green synthesis and anticancer potential of chalcone linked-1,2,3-triazoles.
    Yadav P; Lal K; Kumar A; Guru SK; Jaglan S; Bhushan S
    Eur J Med Chem; 2017 Jan; 126():944-953. PubMed ID: 28011424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective CDK4/6 inhibition of novel 1,2,3-triazole tethered acridinedione derivatives induces G1/S cell cycle transition arrest via Rb phosphorylation blockade in breast cancer models.
    Praveenkumar E; Gurrapu N; Kolluri PK; Shivaraj ; Subhashini NJP; Dokala A
    Bioorg Chem; 2021 Nov; 116():105377. PubMed ID: 34670329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and antimalarial evaluation of novel isocryptolepine derivatives.
    Whittell LR; Batty KT; Wong RP; Bolitho EM; Fox SA; Davis TM; Murray PE
    Bioorg Med Chem; 2011 Dec; 19(24):7519-25. PubMed ID: 22055713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis of neocryptolepines and carbocycle-fused quinolines and evaluation of their anticancer and antiplasmodial activities.
    Akkachairin B; Rodphon W; Reamtong O; Mungthin M; Tummatorn J; Thongsornkleeb C; Ruchirawat S
    Bioorg Chem; 2020 May; 98():103732. PubMed ID: 32171989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design and synthesis of newer 1,3,4-oxadiazole and 1,2,4-triazole based Topsentin analogues as anti-proliferative agent targeting tubulin.
    Naaz F; Ahmad F; Lone BA; Pokharel YR; Fuloria NK; Fuloria S; Ravichandran M; Pattabhiraman L; Shafi S; Shahar Yar M
    Bioorg Chem; 2020 Jan; 95():103519. PubMed ID: 31884140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of Intrinsic Apoptosis and G1 Cell Cycle Arrest by a Triazole Precursor, N-(4-chlorophenyl)-2-(4-(3,4,5-trimethoxybenzyloxy)benzoyl)-hydrazinecarbothioamide in Breast Cancer Cell Line.
    Arulnathan SB; Leong KH; Ariffin A; Kareem HS; Cheah KKH
    Anticancer Agents Med Chem; 2020; 20(9):1072-1086. PubMed ID: 32188392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis and biological evaluation of novel 3-alkylsulfanyl-4-amino-1,2,4-triazole derivatives.
    Zhao PL; Chen P; Li Q; Hu MJ; Diao PC; Pan ES; You WW
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3679-83. PubMed ID: 27287368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis and antifungal activity evaluation of isocryptolepine derivatives.
    Li JC; Wang RX; Sun Y; Zhu JK; Hu GF; Wang YL; Zhou R; Zhao ZM; Liu YQ; Peng JW; Yan YF; Shang XF
    Bioorg Chem; 2019 Nov; 92():103266. PubMed ID: 31542716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and biological evaluation of novel 7-hydroxy-4-phenylchromen-2-one-linked to triazole moieties as potent cytotoxic agents.
    Liu CF; Shen QK; Li JJ; Tian YS; Quan Z
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1111-1119. PubMed ID: 28791908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and anticancer activity of novel rapamycin C-28 containing triazole moiety compounds.
    Huang Q; Xie L; Chen X; Yu H; Lv Y; Huang X; Ying J; Zheng C; Cheng Y; Huang J
    Arch Pharm (Weinheim); 2018 Nov; 351(11):e1800123. PubMed ID: 30357890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and biological evaluation of 1-(benzofuran-3-yl)-4-(3,4,5-trimethoxyphenyl)-1H-1,2,3-triazole derivatives as tubulin polymerization inhibitors.
    Qi ZY; Hao SY; Tian HZ; Bian HL; Hui L; Chen SW
    Bioorg Chem; 2020 Jan; 94():103392. PubMed ID: 31669093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.